ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea flag South Korea · Delayed Price · Currency is KRW
81,500
-700 (-0.85%)
At close: Apr 29, 2026
Market Cap1.28T
Revenue (ttm)26.25B +100.2%
Net Income-2.85B
EPS-222.00
Shares Out15.74M
PE Ration/a
Forward PE149.27
Dividendn/a
Ex-Dividend Daten/a
Volume373,891
Average Volume392,906
Open76,100
Previous Close82,200
Day's Range76,100 - 82,500
52-Week Range13,740 - 153,800
Betan/a
RSI34.10
Earnings DateApr 10, 2026

About ROKIT Healthcare

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376900
Full Company Profile

Financial Performance

In 2025, ROKIT Healthcare's revenue was 26.25 billion, an increase of 100.19% compared to the previous year's 13.11 billion. Losses were -2.85 billion, -62.79% less than in 2024.

Financial Statements